Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.

Cell | 2016

Glucagon and thyroid hormone (T3) exhibit therapeutic potential for metabolic disease but also exhibit undesired effects. We achieved synergistic effects of these two hormones and mitigation of their adverse effects by engineering chemical conjugates enabling delivery of both activities within one precisely targeted molecule. Coordinated glucagon and T3 actions synergize to correct hyperlipidemia, steatohepatitis, atherosclerosis, glucose intolerance, and obesity in metabolically compromised mice. We demonstrate that each hormonal constituent mutually enriches cellular processes in hepatocytes and adipocytes via enhanced hepatic cholesterol metabolism and white fat browning. Synchronized signaling driven by glucagon and T3 reciprocally minimizes the inherent harmful effects of each hormone. Liver-directed T3 action offsets the diabetogenic liability of glucagon, and glucagon-mediated delivery spares the cardiovascular system from adverse T3 action. Our findings support the therapeutic utility of integrating these hormones into a single molecular entity that offers unique potential for treatment of obesity, type 2 diabetes, and cardiovascular disease.

Pubmed ID: 27720451 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Phospho-CREB (Ser133) (87G3) Rabbit mAb (antibody)

RRID:AB_2561044

This monoclonal targets Phospho-CREB (Ser133)

View all literature mentions

Anti-GAPDH Antibody (G-9) (antibody)

RRID:AB_10847862

This monoclonal targets GAPDH

View all literature mentions

Phospho-PKA Substrate (RRXS*/T*) (100G7E) Rabbit mAb (antibody)

RRID:AB_331817

This monoclonal targets Phospho-PKA Substrate (RRXS*/T*)

View all literature mentions

Anti-UCP1 antibody (antibody)

RRID:AB_2241462

This polyclonal targets UCP1

View all literature mentions

B6.129-Ucp1tm1Kz/J (organism)

RRID:IMSR_JAX:003124

Mus musculus with name B6.129-Ucp1tm1Kz/J from IMSR.

View all literature mentions

B6.129S7-Ldlrtm1Her/J (organism)

RRID:IMSR_JAX:002207

Mus musculus with name B6.129S7-Ldlrtm1Her/J from IMSR.

View all literature mentions

C57BL/6J (organism)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

Hep-G2 (cell line)

RRID:CVCL_0027

Cell line Hep-G2 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293 (cell line)

RRID:CVCL_0045

Cell line HEK293 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

Phospho-CREB (Ser133) (87G3) Rabbit mAb (antibody)

RRID:AB_2561044

This monoclonal targets Phospho-CREB (Ser133)

View all literature mentions